請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/17410
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 江皓森(Hao-Sen Chiang) | |
dc.contributor.author | Hsuan-Ju Lai | en |
dc.contributor.author | 賴宣儒 | zh_TW |
dc.date.accessioned | 2021-06-08T00:11:24Z | - |
dc.date.copyright | 2020-08-21 | |
dc.date.issued | 2020 | |
dc.date.submitted | 2020-08-13 | |
dc.identifier.citation | 1. Fakhoury, M., et al., Inflammatory bowel disease: clinical aspects and treatments. J Inflamm Res, 2014. 7: p. 113-20. 2. Ramos, G.P. and K.A. Papadakis, Mechanisms of Disease: Inflammatory Bowel Diseases. Mayo Clin Proc, 2019. 94(1): p. 155-165. 3. Kaplan, G.G. and S.C. Ng, Understanding and Preventing the Global Increase of Inflammatory Bowel Disease. Gastroenterology, 2017. 152(2): p. 313-321 e2. 4. Kaplan, G.G., The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol, 2015. 12(12): p. 720-7. 5. Chang, J., et al., Impaired Intestinal Permeability Contributes to Ongoing Bowel Symptoms in Patients With Inflammatory Bowel Disease and Mucosal Healing. Gastroenterology, 2017. 153(3): p. 723-731 e1. 6. Michielan, A. and R. D'Inca, Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut. Mediators Inflamm, 2015. 2015: p. 628157. 7. Bohonak, A.J., IBD (Isolation by Distance): a program for analyses of isolation by distance. J Hered, 2002. 93(2): p. 153-4. 8. Pithadia, A.B. and S. Jain, Treatment of inflammatory bowel disease (IBD). Pharmacol Rep, 2011. 63(3): p. 629-42. 9. Muthas, D., et al., Neutrophils in ulcerative colitis: a review of selected biomarkers and their potential therapeutic implications. Scand J Gastroenterol, 2017. 52(2): p. 125-135. 10. Stallhofer, J., et al., Lipocalin-2 Is a Disease Activity Marker in Inflammatory Bowel Disease Regulated by IL-17A, IL-22, and TNF-alpha and Modulated by IL23R Genotype Status. Inflamm Bowel Dis, 2015. 21(10): p. 2327-40. 11. Kong, S., Y.H. Zhang, and W. Zhang, Regulation of Intestinal Epithelial Cells Properties and Functions by Amino Acids. Biomed Res Int, 2018. 2018: p. 2819154. 12. Totafurno, J., M. Bjerknes, and H. Cheng, The crypt cycle. Crypt and villus production in the adult intestinal epithelium. Biophys J, 1987. 52(2): p. 279-94. 13. Allaire, J.M., et al., The Intestinal Epithelium: Central Coordinator of Mucosal Immunity: (Trends in Immunology 39, 677-696, 2018). Trends Immunol, 2019. 40(2): p. 174. 14. Okumura, R. and K. Takeda, Roles of intestinal epithelial cells in the maintenance of gut homeostasis. Exp Mol Med, 2017. 49(5): p. e338. 15. Kulkarni, N., M. Pathak, and G. Lal, Role of chemokine receptors and intestinal epithelial cells in the mucosal inflammation and tolerance. J Leukoc Biol, 2017. 101(2): p. 377-394. 16. Price, A.E., et al., A Map of Toll-like Receptor Expression in the Intestinal Epithelium Reveals Distinct Spatial, Cell Type-Specific, and Temporal Patterns. Immunity, 2018. 49(3): p. 560-575 e6. 17. Parlato, M. and G. Yeretssian, NOD-like receptors in intestinal homeostasis and epithelial tissue repair. Int J Mol Sci, 2014. 15(6): p. 9594-627. 18. Chelakkot, C., J. Ghim, and S.H. Ryu, Mechanisms regulating intestinal barrier integrity and its pathological implications. Exp Mol Med, 2018. 50(8): p. 103. 19. Campbell, H.K., J.L. Maiers, and K.A. DeMali, Interplay between tight junctions adherens junctions. Exp Cell Res, 2017. 358(1): p. 39-44. 20. Anderson, J.M. and C.M. Van Itallie, Physiology and function of the tight junction. Cold Spring Harb Perspect Biol, 2009. 1(2): p. a002584. 21. Gunzel, D. and A.S. Yu, Claudins and the modulation of tight junction permeability. Physiol Rev, 2013. 93(2): p. 525-69. 22. Fanning, A.S., et al., The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton. J Biol Chem, 1998. 273(45): p. 29745-53. 23. Coopman, P. and A. Djiane, Adherens Junction and E-Cadherin complex regulation by epithelial polarity. Cell Mol Life Sci, 2016. 73(18): p. 3535-53. 24. Halbleib, J.M. and W.J. Nelson, Cadherins in development: cell adhesion, sorting, and tissue morphogenesis. Genes Dev, 2006. 20(23): p. 3199-214. 25. Angst, B.D., C. Marcozzi, and A.I. Magee, The cadherin superfamily: diversity in form and function. J Cell Sci, 2001. 114(Pt 4): p. 629-41. 26. Rikitake, Y., K. Mandai, and Y. Takai, The role of nectins in different types of cell-cell adhesion. J Cell Sci, 2012. 125(Pt 16): p. 3713-22. 27. Pope, J.L., et al., Claudin-1 regulates intestinal epithelial homeostasis through the modulation of Notch-signalling. Gut, 2014. 63(4): p. 622-34. 28. Bhat, A.A., et al., Tight Junction Proteins and Signaling Pathways in Cancer and Inflammation: A Functional Crosstalk. Front Physiol, 2018. 9: p. 1942. 29. Schulzke, J.D., et al., Epithelial tight junctions in intestinal inflammation. Ann N Y Acad Sci, 2009. 1165: p. 294-300. 30. Landy, J., et al., Tight junctions in inflammatory bowel diseases and inflammatory bowel disease associated colorectal cancer. World J Gastroenterol, 2016. 22(11): p. 3117-26. 31. De Mey, J.R. and J.N. Freund, Understanding epithelial homeostasis in the intestine: An old battlefield of ideas, recent breakthroughs and remaining controversies. Tissue Barriers, 2013. 1(2): p. e24965. 32. Goto, Y. and Ivanov, II, Intestinal epithelial cells as mediators of the commensal-host immune crosstalk. Immunol Cell Biol, 2013. 91(3): p. 204-14. 33. Gibson, P.R., et al., Ulcerative colitis--a disease characterised by the abnormal colonic epithelial cell? Gut, 1988. 29(4): p. 516-21. 34. Vrakas, S., et al., Intestinal Bacteria Composition and Translocation of Bacteria in Inflammatory Bowel Disease. PLoS One, 2017. 12(1): p. e0170034. 35. McGuckin, M.A., et al., Intestinal barrier dysfunction in inflammatory bowel diseases. Inflamm Bowel Dis, 2009. 15(1): p. 100-13. 36. Amulic, B., et al., Neutrophil function: from mechanisms to disease. Annu Rev Immunol, 2012. 30: p. 459-89. 37. Rosales, C., Neutrophil: A Cell with Many Roles in Inflammation or Several Cell Types? Front Physiol, 2018. 9: p. 113. 38. Teng, T.S., et al., Neutrophils and Immunity: From Bactericidal Action to Being Conquered. J Immunol Res, 2017. 2017: p. 9671604. 39. Segal, A.W., How neutrophils kill microbes. Annu Rev Immunol, 2005. 23: p. 197-223. 40. Hurst, J.K., What really happens in the neutrophil phagosome? Free Radic Biol Med, 2012. 53(3): p. 508-20. 41. Lacy, P., Mechanisms of degranulation in neutrophils. Allergy Asthma Clin Immunol, 2006. 2(3): p. 98-108. 42. Brinkmann, V., et al., Neutrophil extracellular traps kill bacteria. Science, 2004. 303(5663): p. 1532-5. 43. Yipp, B.G. and P. Kubes, NETosis: how vital is it? Blood, 2013. 122(16): p. 2784-94. 44. Van Avondt, K. and D. Hartl, Mechanisms and disease relevance of neutrophil extracellular trap formation. Eur J Clin Invest, 2018. 48 Suppl 2: p. e12919. 45. Karlsson, A., J.B. Nixon, and L.C. McPhail, Phorbol myristate acetate induces neutrophil NADPH-oxidase activity by two separate signal transduction pathways: dependent or independent of phosphatidylinositol 3-kinase. J Leukoc Biol, 2000. 67(3): p. 396-404. 46. Hakkim, A., et al., Activation of the Raf-MEK-ERK pathway is required for neutrophil extracellular trap formation. Nat Chem Biol, 2011. 7(2): p. 75-7. 47. Remijsen, Q., et al., Neutrophil extracellular trap cell death requires both autophagy and superoxide generation. Cell Res, 2011. 21(2): p. 290-304. 48. Papayannopoulos, V., Neutrophil extracellular traps in immunity and disease. Nat Rev Immunol, 2018. 18(2): p. 134-147. 49. Urban, C.F., et al., Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans. PLoS Pathog, 2009. 5(10): p. e1000639. 50. Weintraub, H., K. Palter, and F. Van Lente, Histones H2a, H2b, H3, and H4 form a tetrameric complex in solutions of high salt. Cell, 1975. 6(1): p. 85-110. 51. Allan, J., et al., The structure of histone H1 and its location in chromatin. Nature, 1980. 288(5792): p. 675-9. 52. Hoeksema, M., et al., Histones as mediators of host defense, inflammation and thrombosis. Future Microbiol, 2016. 11(3): p. 441-53. 53. Xu, J., et al., Extracellular histones are major mediators of death in sepsis. Nat Med, 2009. 15(11): p. 1318-21. 54. Saffarzadeh, M., et al., Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones. PLoS One, 2012. 7(2): p. e32366. 55. Stapels, D.A., B.V. Geisbrecht, and S.H. Rooijakkers, Neutrophil serine proteases in antibacterial defense. Curr Opin Microbiol, 2015. 23: p. 42-8. 56. Doring, G., The role of neutrophil elastase in chronic inflammation. Am J Respir Crit Care Med, 1994. 150(6 Pt 2): p. S114-7. 57. Owen, C.A. and E.J. Campbell, The cell biology of leukocyte-mediated proteolysis. J Leukoc Biol, 1999. 65(2): p. 137-50. 58. Smedly, L.A., et al., Neutrophil-mediated injury to endothelial cells. Enhancement by endotoxin and essential role of neutrophil elastase. J Clin Invest, 1986. 77(4): p. 1233-43. 59. Aratani, Y., Myeloperoxidase: Its role for host defense, inflammation, and neutrophil function. Arch Biochem Biophys, 2018. 640: p. 47-52. 60. Eiserich, J.P., et al., Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature, 1998. 391(6665): p. 393-7. 61. Petruska, J.M., et al., Myeloperoxidase-enhanced formation of (+-)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene-DNA adducts in lung tissue in vitro: a role of pulmonary inflammation in the bioactivation of a procarcinogen. Carcinogenesis, 1992. 13(7): p. 1075-81. 62. Tang, S., et al., Neutrophil extracellular trap formation is associated with autophagy-related signalling in ANCA-associated vasculitis. Clin Exp Immunol, 2015. 180(3): p. 408-18. 63. Kessenbrock, K., et al., Netting neutrophils in autoimmune small-vessel vasculitis. Nat Med, 2009. 15(6): p. 623-5. 64. Khandpur, R., et al., NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Sci Transl Med, 2013. 5(178): p. 178ra40. 65. Garcia-Romo, G.S., et al., Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci Transl Med, 2011. 3(73): p. 73ra20. 66. Duewell, P., et al., NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature, 2010. 464(7293): p. 1357-61. 67. Thomas, G.M., et al., Extracellular DNA traps are associated with the pathogenesis of TRALI in humans and mice. Blood, 2012. 119(26): p. 6335-43. 68. Kolaczkowska, E., et al., Molecular mechanisms of NET formation and degradation revealed by intravital imaging in the liver vasculature. Nat Commun, 2015. 6: p. 6673. 69. Fuchs, T.A., et al., Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci U S A, 2010. 107(36): p. 15880-5. 70. Qin, J., et al., NETosis-associated serum biomarkers are reduced in type 1 diabetes in association with neutrophil count. Clin Exp Immunol, 2016. 184(3): p. 318-22. 71. Wong, S.L., et al., Diabetes primes neutrophils to undergo NETosis, which impairs wound healing. Nat Med, 2015. 21(7): p. 815-9. 72. Bennike, T.B., et al., Neutrophil Extracellular Traps in Ulcerative Colitis: A Proteome Analysis of Intestinal Biopsies. Inflamm Bowel Dis, 2015. 21(9): p. 2052-67. 73. Kirchner, T., et al., The impact of various reactive oxygen species on the formation of neutrophil extracellular traps. Mediators Inflamm, 2012. 2012: p. 849136. 74. Alzoghaibi, M.A., Concepts of oxidative stress and antioxidant defense in Crohn's disease. World J Gastroenterol, 2013. 19(39): p. 6540-7. 75. Shackelford, C., et al., Qualitative and quantitative analysis of nonneoplastic lesions in toxicology studies. Toxicol Pathol, 2002. 30(1): p. 93-6. 76. Grayson, P.C. and M.J. Kaplan, At the Bench: Neutrophil extracellular traps (NETs) highlight novel aspects of innate immune system involvement in autoimmune diseases. J Leukoc Biol, 2016. 99(2): p. 253-64. 77. Lee, K.H., et al., Neutrophil extracellular traps (NETs) in autoimmune diseases: A comprehensive review. Autoimmun Rev, 2017. 16(11): p. 1160-1173. 78. Snoderly, H.T., B.A. Boone, and M.F. Bennewitz, Neutrophil extracellular traps in breast cancer and beyond: current perspectives on NET stimuli, thrombosis and metastasis, and clinical utility for diagnosis and treatment. Breast Cancer Res, 2019. 21(1): p. 145. 79. Delgado-Rizo, V., et al., Neutrophil Extracellular Traps and Its Implications in Inflammation: An Overview. Front Immunol, 2017. 8: p. 81. 80. Gupta, A.K., et al., Activated endothelial cells induce neutrophil extracellular traps and are susceptible to NETosis-mediated cell death. FEBS Lett, 2010. 584(14): p. 3193-7. 81. Villanueva, E., et al., Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus. J Immunol, 2011. 187(1): p. 538-52. 82. Kaplan, M.J. and M. Radic, Neutrophil extracellular traps: double-edged swords of innate immunity. J Immunol, 2012. 189(6): p. 2689-95. 83. Dinallo, V., et al., Neutrophil Extracellular Traps Sustain Inflammatory Signals in Ulcerative Colitis. J Crohns Colitis, 2019. 13(6): p. 772-784. 84. Raleigh, D.R., et al., Occludin S408 phosphorylation regulates tight junction protein interactions and barrier function. J Cell Biol, 2011. 193(3): p. 565-82. 85. Carmona-Rivera, C., et al., Neutrophil extracellular traps induce endothelial dysfunction in systemic lupus erythematosus through the activation of matrix metalloproteinase-2. Ann Rheum Dis, 2015. 74(7): p. 1417-24. 86. Lai, J.J., F.M. Cruz, and K.L. Rock, Immune Sensing of Cell Death through Recognition of Histone Sequences by C-Type Lectin-Receptor-2d Causes Inflammation and Tissue Injury. Immunity, 2020. 52(1): p. 123-135 e6. 87. Sugi, K., et al., Fecal lactoferrin as a marker for disease activity in inflammatory bowel disease: comparison with other neutrophil-derived proteins. Am J Gastroenterol, 1996. 91(5): p. 927-34. 88. Walsham, N.E. and R.A. Sherwood, Fecal calprotectin in inflammatory bowel disease. Clin Exp Gastroenterol, 2016. 9: p. 21-9. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/17410 | - |
dc.description.abstract | 發炎性腸道疾病 (Inflammatory bowel disease, IBD) 是一種腸道的自體免疫疾病,因為腸道免疫系統對腸道共生微生物產生不正常的免疫反應,使得腸道發炎伴隨腹瀉、直腸出血等症狀。近期有研究指出在潰瘍性大腸炎(Ulcerative colitis)患者的腸子內,可以看到嗜中性球(neutrophil)的浸潤的上升,並且根據蛋白質體分析結果,發現許多跟嗜中性白血球細胞外網狀結構(Neutrophil extracellular traps , NETs)相關蛋白,在潰瘍性大腸炎患者的大腸中比正常受試者的數量多很多,指出嗜中性球細胞外網對於發炎性腸道疾病而言可能是個不利的因素。 嗜中性白血球細胞外網狀結構(Neutrophil extracellular traps , NETs) 會將自身含有抗微生物蛋白的DNA吐出釋放到胞外形成網狀結構,以限制並進一步清除外來微生物,此網狀結構主要包含嗜中性球本身DNA骨架和纏繞在上的抗微生物蛋白例如:組蛋白(histone)、骨髓過氧化酶(myeloperoxidase, MPO)和嗜中性球彈性蛋白酶(neutrophil elastase, NE)。我們實驗室先前的研究發現當使用葡聚糖硫酸(dextran sulfate sodium, DSS)或三硝基苯磺酸(2,4,6-trinitrobenzene sulfonic acid, TNBS)誘發C57BL/6小鼠產生似人類潰瘍性結腸炎的症狀時,如果以尾靜脈注射去氧核醣核酸酶 I(Deoxyribonuclease I, DNase I)作為抑制嗜中性球細胞外網結構之藥物,腸道上皮細胞的破壞程度明顯比沒有注射去氧核醣核酸酶 I的老鼠來的輕微,腸道通透度也比較低,指出在小鼠C57BL/6大腸內嗜中性球胞外網狀結構雖然是一種抵抗微生物的免疫防禦機制,但卻對腸道上皮會具有破壞的現象。 由於以上研究皆為活體內實驗,為了探討在細胞層面嗜中性白血球胞外網狀結構對腸道上皮的破壞,和找出其造成腸道上皮破壞的成分,本篇研究利用人類大腸上皮細胞株Caco-2進行實驗。在Caco-2中加入嗜中性白血球細胞外網狀結構後,代表細胞凋亡訊號的乳酸去氫酶(lactate dehydrogenase, LDH)釋放,和代表上皮細胞通透度的跨上皮電阻值(transepithelial electrical resistance, TEER)變化、穿透過細胞的螢光異硫氰酸鹽(Fluorescein isothiocyanate, FITC)都有顯著增加。嗜中性白血球胞外網狀結構主要為去氧核醣核酸、組蛋白、骨髓過氧化酶和嗜中性球彈性蛋白酶,在Caco-2中加入預先用高溫去除蛋白活性的嗜中性白血球胞外網狀結構,可以明顯看到細胞凋亡信號和通透度的回復,但加入預先用去氧核醣核酸酶 I切割DNA的的嗜中性白血球胞外網狀結構還是維持很高的細胞凋亡信號跟通透度變化,顯示嗜中性白血球胞外網狀結構中的蛋白質而非DNA造成上皮細胞的傷害造成上皮細胞的傷害。而在嗜中性球細胞外網中抑制組蛋白後,上皮細胞受損的現象明顯減緩,但抑制骨髓過氧化酶和嗜中性球彈性蛋白酶後,就沒有這樣的現象,顯示嗜中性白血球胞外網狀結構中的組蛋白是造成上皮細胞的傷害的主要成分。同樣的,我們在Caco-2中直接加入純化的組蛋白後,可以看到明顯上升的細胞毒性和通透度,但在加入骨髓過氧化酶和嗜中性球彈性蛋白酶就沒有這樣的現象。 並且從螢光染色圖跟西方墨點法測量蛋白表現量後可以看到上皮細胞的細胞間連接蛋白(junction protein)在加入嗜中性白血球細胞外網狀結構和組蛋白後被破壞。而在嗜中性球細胞外網狀結構中預先抑制組蛋白,上皮細胞就可以恢復正常連接蛋白的型態和分佈,但預先抑制骨髓過氧化酶和嗜中性球彈性蛋白酶,上皮細胞仍維持被破壞的型態,說明嗜中性球細胞外網狀結構透過它的成份組蛋白去影響上皮細胞間的連接蛋白。最後,在直腸注射組蛋白到小鼠體內後發現,組蛋白也會影響小鼠腸道免疫細胞浸潤、通透度、連接蛋白表現和上皮細胞的凋亡。 總結我們的發現,嗜中性白血球細胞外網狀結構狀結構透過它的成份組蛋白造成細胞的傷害、腸道上皮細胞通透度上升和連接蛋白的破壞。 | zh_TW |
dc.description.abstract | Inflammatory bowel disease (IBD) is an autoimmune disease characterized by chronic inflammation that causes diarrhea, abdominal pain, and fecal bleeding to patients. Previous studies have observed that the numbers of neutrophils and neutrophil extracellular traps (NETs)-related proteins are highly elevated in the inflamed intestine during colitis, suggesting a prominent role of NET in colitis development. Recently we have shown that DNase I treatments that dissociate NET structure prevent colonic epithelial cell death in mice with Dextran Sulfate Sodium (DSS)-induced colitis. However, the specific NET components that are responsible for cell damage in the intestinal epithelium remains unknown. Given that NETs are mainly composed of DNA, histone, myeloperoxidase (MPO), and neutrophil elastase (NE), here we utilized human intestinal epithelial cell line, Caco-2 to interrogate the impact of each above component on cell cytotoxicity and permeability. Upon incubation with Caco-2 monolayers, NETs induced lactate dehydrogenase (LDH) level, reduced transepithelial electrical resistance (TEER) and Fluorescein isothiocyanate (FITC) dextran leakage. However, protein denaturation in NETs protected the Caco-2 monolayers from the increased cell cytotoxicity and permeability. In contrast, there was no difference in Caco-2 cytotoxicity and permeability when the DNA backbone of NETs was digested. These results indicate that protein is responsible for the cell damage of NETs. Moreover, inhibition of histone by polysialic acid (PSA) in NETs protected the Caco-2 monolayers from the increased cell cytotoxicity and permeability while there was no difference in Caco-2 cytotoxicity and permeability when the activity of MPO or NE was inhibited. Consistently, there was a marked increase in cell cytotoxicity and permeability of Caco-2 monolayers incubated with purified histone but not MPO or NE. Furthermore, immunofluorescence staining and western blot also found that incubation with NETs significantly destroyed tight junction and adherens junction proteins in Caco-2 cells that can be rescued by the inhibition of histones in NETs. In vivo studies further demonstrated that intra-rectal administration of histones in mice altered intestinal permeability, tight junction and adherens junction integrity, epithelial cell death, and immune cell infiltration. In summary, our results suggest that NETs cause cell damage and increase the permeability of colon epithelial cells, particularly through histones. | en |
dc.description.provenance | Made available in DSpace on 2021-06-08T00:11:24Z (GMT). No. of bitstreams: 1 U0001-0508202016412500.pdf: 7026028 bytes, checksum: a989ac40aa07d78d8682b48d1676164b (MD5) Previous issue date: 2020 | en |
dc.description.tableofcontents | 致謝 iii 中文摘要 v Abstract viii Contents xi Chapter 1 Introduction 1 1.1 Inflammatory bowel disease (IBD) 1 1.1.1 Ulcerative colitis and Crohn’s disease 2 1.1.2 Current treatments for IBD 2 1.1.3 Neutrophils in IBD 3 1.2 Intestinal epithelium 3 1.2.1 Intestinal epithelium cell 4 1.2.2 Tight junction and adherens junctions 4 1.2.3 Gut homeostasis 6 1.3 Neutrophils 7 1.3.1 Neutrophils antimicrobial mechanism 7 1.3.2 Process of NETosis 8 1.3.3 NETs components 9 1.3.4 NETs in diseases 11 1.3.5 NETs in IBD 12 1.4 Rationale and Specific Aim 12 Chapter 2 Materials and methods 14 2.1 Cell line 14 2.2 Caco-2 monolayer 14 2.3 Neutrophil isolation 15 2.4 NET production, isolation and quantification 15 2.5 Treatment of Caco-2 cell with NET 16 2.6 Myeloperoxidase(MPO) Activity Test and Neutrophil Elastase(NE) Activity Test 17 2.7 Lactate dehydrogenase (LDH) assay 18 2.8 Transepithelial electrical resistance (TEER) measuring 19 2.9 Caco-2 monolayer permeability assay –FITC-dextran 19 2.10 Fluorescence staining of Caco-2 transwell monolayer 20 2.11 Western Blotting 21 2.12 Mice 22 2.13 Intra-rectal (i.r.) injection of histone 22 2.14 Intestinal permeability assay –FITC-dextran 23 2.15 Hematoxylin and eosin (H E) staining 24 2.16 Histopathological analysis 24 2.17 Fluorescence staining of colon tissue 25 2.18 TUNEL assay 26 Chapter 3 Results 28 3.1 The protein components of NETs are responsible for the intestinal epithelial cell death of nonpolarized Caco-2 cells. 28 3.2 Histones are the major components in NETs to induce intestinal epithelial cell death of nonpolarized Caco-2 cells. 28 3.3 Histones are the major components in NETs to induce intestinal epithelial cell death and increase permeability of Caco-2 monolayers. 29 3.4 NETs negatively regulate the expression and integrity of tight junction and adherens junction proteins by NETs-associated histones. 31 3.5 Intra-rectal administration of histones impairs intestinal barrier integrity and induces epithelial cell death in the mouse colon. 33 Chapter 4 Discussion 35 Chapter 5 Conclusion 38 Figures 39 Reference 51 | |
dc.language.iso | en | |
dc.title | 探討嗜中性球胞外網狀結構中會影響腸道上皮細胞屏障完整性的成份 | zh_TW |
dc.title | Investigate the components of NETs responsible for barrier integrity in the intestinal epithelium | en |
dc.type | Thesis | |
dc.date.schoolyear | 108-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 魏淑鉁(Shu-Chen Wei),余佳慧(Chia-Hui Yu) | |
dc.subject.keyword | 嗜中性球,嗜中性球胞外網,發炎性腸道疾病,組蛋白,連接蛋白, | zh_TW |
dc.subject.keyword | Neutrophils,Neutrophil extracellular traps,IBD,Histone,tight junction,adherens junction, | en |
dc.relation.page | 77 | |
dc.identifier.doi | 10.6342/NTU202002484 | |
dc.rights.note | 未授權 | |
dc.date.accepted | 2020-08-14 | |
dc.contributor.author-college | 生命科學院 | zh_TW |
dc.contributor.author-dept | 生命科學系 | zh_TW |
顯示於系所單位: | 生命科學系 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
U0001-0508202016412500.pdf 目前未授權公開取用 | 6.86 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。